赛隆药业：子公司申请2000万元综合授信额度，公司拟提供担保

Core Viewpoint - The company announced that its board approved a proposal for its subsidiaries to apply for a total credit limit of 20 million yuan, which requires shareholder approval [1] Group 1: Company Actions - The company plans for its subsidiaries, Hunan Sailong Pharmaceutical Co., Ltd. and Hunan Sailong Pharmaceutical (Changsha) Co., Ltd., to apply for credit limits of 10 million yuan each from Shanghai Pudong Development Bank Changsha Biopharmaceutical Branch, totaling 20 million yuan [1] - The company intends to provide guarantee collateral for these two subsidiaries, which will use their own assets for mortgage guarantees [1] Group 2: Financial Implications - As of the announcement date, the total amount of guarantees provided by the company is 310 million yuan, accounting for 62.09% of the audited net assets for the year 2024 [1] - The actual amount of guarantees stands at 293 million yuan, representing 58.66% of the audited net assets for the year 2024 [1]